Literature DB >> 10372551

Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms.

X Wang1, G Tromp, C W Cole, A Verloes, N Sakalihasan, S Yoon, H Kuivaniemi.   

Abstract

Aneurysms are characterized by dilation, i.e. expansion and thinning of all the arterial wall layers, which is accompanied by remodeling of the connective tissue. Genes involved in the regulation of tissue remodeling are therefore candidate genes. We analyzed TIMP1 and TIMP2 coding sequences in 12 individuals with abdominal aortic aneurysms (AAA), one individual with AAA and intracranial aneurysms (IA), four individuals with IA and two clinically unaffected individuals. We identified two nucleotide variants in both the TIMP1 and the TIMP2 coding sequences. All differences occurred in the third base positions of codons and were neutral polymorphisms. A significant difference was observed in the frequency of TIMP2 nt 573 polymorphism between 168 alleles from AAA patients and 102 control alleles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372551     DOI: 10.1016/s0945-053x(99)00008-6

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  10 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 3.  Genes and abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Gerard Tromp; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2010-12-13       Impact factor: 1.466

4.  Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.

Authors:  Toru Ogata; Hidenori Shibamura; Gerard Tromp; Moumita Sinha; Katrina A B Goddard; Natzi Sakalihasan; Raymond Limet; Gerald L MacKean; Claudette Arthur; Taijiro Sueda; Susan Land; Helena Kuivaniemi
Journal:  J Vasc Surg       Date:  2005-06       Impact factor: 4.268

5.  A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.

Authors:  F Lose; P J Thompson; D Duffy; G A Stewart; M-A Kedda
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

6.  Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Dietmar Krex; Eberhard Kuhlisch; Karl G Schmidt; Christian Pilarsky; Wolfgang Schneiders; Hans D Saeger; Hendrik Bergert
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

Review 7.  Matrix metalloproteinases and atherosclerosis.

Authors:  Noboru Watanabe; Uichi Ikeda
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

8.  Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

Authors:  F J G M Kubben; C F M Sier; M J W Meijer; M van den Berg; J J van der Reijden; G Griffioen; C J H van de Velde; C B H W Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  2006-08-29       Impact factor: 7.640

9.  Widespread DNA hypomethylation and differential gene expression in Turner syndrome.

Authors:  Christian Trolle; Morten Muhlig Nielsen; Anne Skakkebæk; Philippe Lamy; Søren Vang; Jakob Hedegaard; Iver Nordentoft; Torben Falck Ørntoft; Jakob Skou Pedersen; Claus Højbjerg Gravholt
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

Review 10.  Genetic and Epigenetic Mechanisms Underlying Vascular Smooth Muscle Cell Phenotypic Modulation in Abdominal Aortic Aneurysm.

Authors:  Rijan Gurung; Andrew Mark Choong; Chin Cheng Woo; Roger Foo; Vitaly Sorokin
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.